The beauty conglomerate has joined with biotechnology and pharmaceutical company Serpin Pharma for ingredient research.

Shares of Estee Lauder Cos. Cl A EL shed 2.01% to $73.28 Wednesday, on what proved to be an all-around mixed trading session ...

Under Armour has tapped Liz Bacelar, former executive director of global tech innovation at Estée Lauder, as its new head of ...

Bell Asset Management, an investment management company, released its Q4 2024 “Bell Global Equities Fund” investor letter. A ...

Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 ...

If you're a devoted Estée Lauder fan looking to expand your collection or simply searching for a skincare upgrade, this ...

Estée Lauder has announced actor, writer, model and anti-ageism activist Paulina Porizkova, will return to the brand as its ...

Bobbi Brown's V itamin Enriched Face Base is another much-loved and much-duped product, and Poundland's got its own version ...

Would you like to be notified of the latest news and updates on the stock market?

This was the stock's second consecutive day of gains.

The move forms part of ELC’s newly unveiled Beauty Reimagined strategic vision, which aims to help the company return to ...

Estee Lauder (EL) announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory ...